Fingolimod D4 Hydrochloride

Fingolimod D4 Hydrochloride is a deuterated form of Fingolimod Hydrochloride, a synthetic analogue of sphingosine that is used as an immunomodulatory agent. It is primarily used in the treatment of multiple sclerosis, a chronic autoimmune disease that affects the central nervous system. The chemical structure of Fingolimod D4 Hydrochloride consists of a sphingosine-like backbone with a polar head group and an alkyl tail. It works by binding to sphingosine-1-phosphate (S1P) receptors on lymphocytes, which prevents their migration from lymphoid tissues into the bloodstream and CNS. This reduces the number of immune cells that can cause inflammation in the CNS, thereby reducing the frequency and severity of MS relapses. Fingolimod D4 Hydrochloride is typically administered orally, usually in the form of a capsule or tablet. The recommended dosage varies depending on the patient's age, weight, and medical history. It is important to follow the prescribed dosage and frequency of administration to ensure maximum efficacy and minimize the risk of adverse effects. In terms of chemical information, Fingolimod D4 Hydrochloride has a molecular formula of C19H33D4NO2.HCl and a molecular weight of 358.05 g/mol. It is a white to off-white crystalline powder that is soluble in water and methanol. It is stable under normal conditions of use and storage, but should be protected from light and moisture.